Latest CAXTON CORP Stock Portfolio
CAXTON CORP Performance:
2024 Q4: 9.79%YTD: 60.11%2023: 67.85%
Performance for 2024 Q4 is 9.79%, and YTD is 60.11%, and 2023 is 67.85%.
About CAXTON CORP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, CAXTON CORP reported an equity portfolio of $16.6 Millions as of 31 Dec, 2024.
The top stock holdings of CAXTON CORP are XERS, RZLT, SPY. The fund has invested 41.1% of it's portfolio in XERIS BIOPHARMA HOLDINGS INC and 38.8% of portfolio in REZOLUTE INC.
The fund managers got completely rid off ABIVAX SA stocks. They significantly reduced their stock positions in XERIS BIOPHARMA HOLDINGS INC (XERS), BERKSHIRE HATHAWAY INC DEL and SPDR S&P 500 ETF TR (SPY). CAXTON CORP opened new stock positions in SPDR GOLD TR (GLD), CARDIFF ONCOLOGY INC (CRDF) and INHIBIKASE THERAPEUTICS INC (IKT).
The top stock holdings of CAXTON CORP are XERS, RZLT, SPY. The fund has invested 41.1% of it's portfolio in XERIS BIOPHARMA HOLDINGS INC and 38.8% of portfolio in REZOLUTE INC.
The fund managers got completely rid off ABIVAX SA stocks. They significantly reduced their stock positions in XERIS BIOPHARMA HOLDINGS INC (XERS), BERKSHIRE HATHAWAY INC DEL and SPDR S&P 500 ETF TR (SPY). CAXTON CORP opened new stock positions in SPDR GOLD TR (GLD), CARDIFF ONCOLOGY INC (CRDF) and INHIBIKASE THERAPEUTICS INC (IKT).
CAXTON CORP Annual Return Estimates Vs S&P 500
Our best estimate is that CAXTON CORP made a return of 9.79% in the last quarter. In trailing 12 months, it's portfolio return was 60.11%.
New Buys
| Ticker | $ Bought |
|---|---|
| spdr gold tr | 283,068 |
| cardiff oncology inc | 57,665 |
| inhibikase therapeutics inc | 53,277 |
| glycomimetics inc | 50,895 |
New stocks bought by CAXTON CORP
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| xeris biopharma holdings inc | -60.59 |
| berkshire hathaway inc del | -1.56 |
| spdr s&p 500 etf tr | -1.53 |
CAXTON CORP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| abivax sa | -130,925 |
CAXTON CORP got rid off the above stocks
Sector Distribution
CAXTON CORP has about 82.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 82.9 |
| Others | 17.1 |
Market Cap. Distribution
CAXTON CORP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 42.5 |
| MICRO-CAP | 39.8 |
| UNALLOCATED | 17.1 |
Stocks belong to which Index?
About 41.5% of the stocks held by CAXTON CORP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 58.5 |
| RUSSELL 2000 | 41.5 |
CAXTON CORP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of CAXTON CORP
CAXTON CORP has 15 stocks in it's portfolio. About 98.8% of the portfolio is in top 10 stocks. CMPX proved to be the most loss making stock for the portfolio. XERS was the most profitable stock for CAXTON CORP last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 0.10 | 17,488 | 16,823 | unchanged | 0.00 | ||
| CMPX | compass therapeutics inc | 0.38 | 43,465 | 63,025 | unchanged | 0.00 | ||
| CNTX | context therapeutics inc | 0.12 | 18,403 | 19,324 | unchanged | 0.00 | ||
| CRDF | cardiff oncology inc | 0.35 | 13,287 | 57,665 | new | |||
| GLD | spdr gold tr | 1.70 | 1,169 | 283,068 | new | |||
| GLYC | glycomimetics inc | 0.31 | 203,578 | 50,895 | new | |||
| IKT | inhibikase therapeutics inc | 0.32 | 16,393 | 53,277 | new | |||
| MNMD | mind medicine mindmed inc | 1.43 | 34,073 | 237,149 | unchanged | 0.00 | ||
| RZLT | rezolute inc | 38.84 | 1,318,970 | 6,462,940 | unchanged | 0.00 | ||
| SPY | spdr s&p 500 etf tr | 9.94 | 2,823 | 1,654,490 | reduced | -1.53 | ||
| XERS | xeris biopharma holdings inc | 41.06 | 2,015,160 | 6,831,380 | reduced | -60.59 | ||
| berkshire hathaway inc del | 3.09 | 1,133 | 513,554 | reduced | -1.56 | |||
| bicara therapeutics inc | 1.15 | 10,941 | 190,593 | unchanged | 0.00 | |||
| lexeo therapeutics inc | 0.71 | 17,851 | 117,460 | unchanged | 0.00 | |||
| kyverna therapeutics inc | 0.52 | 22,981 | 85,950 | unchanged | 0.00 | |||
| abivax sa | 0.00 | 0.00 | 0.00 | sold off | -100 | |||